Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Strieth

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Laryngoscope Investigative Otolaryngology|October 19, 2022
MR-lymphangiography identifies lymphatic pathologies in patients with idiopathic recurrent cervical swellingMarius Vach, Julia Wagenpfeil, Andreas Henkel, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|September 28, 2012
Phase I clinical study of vascular targeting fluorescent cationic liposomes in head and neck cancerSebastian Strieth, Christoph Dunau, Kristina Kolbow, et al.
Pigment Cell & Melanoma Research|November 17, 2023
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanomaLuka de Vos-Hillebrand, Simon Fietz, Philip Hillebrand, et al.
Journal of Materials Chemistry. B|August 10, 2021
Photocleavable core cross-linked polymeric micelles of polypept(o)ides and ruthenium(II) complexesTobias Alexander Bauer, Jonas Eckrich, Nadine Wiesmann, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 7, 2023
Randomized, placebo-controlled study on efficacy, safety and tolerability of drug-induced defibrinogenation for sudden sensorineural hearing loss: the lessons learnedBernhard G Weiss, Jennifer L Spiegel, Sven Becker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2021
DNA Methylation and mRNA Expression of OX40 (TNFRSF4) and GITR (TNFRSF18, AITR) in Head and Neck Squamous Cell Carcinoma Correlates With HPV Status, Mutational Load, an Interferon-γ Signature, Signatures of Immune Infiltrates, and SurvivalSophia M Loick, Anne Fröhlich, Jennis Gabrielpillai, et al.
International Journal of Molecular Sciences|March 11, 2023
Exploiting Vitamin D Receptor and Its Ligands to Target Squamous Cell Carcinomas of the Head and NeckLaura Koll, Désirée Gül, Manal I Elnouaem, et al.
Medical Ultrasonography|September 9, 2020
Evaluation of optimal education level to implement structured reporting into ultrasound trainingBenjamin Philipp Ernst, Sebastian Strieth, Julian Künzel, et al.
Cancer Biology & Therapy|March 18, 2010
Vascular targeting tumor therapy: non-invasive contrast enhanced ultrasound for quantitative assessment of tumor microcirculationMartin E Eichhorn, Laura V Klotz, Siiri Luedemann, et al.
Cancer Immunology, Immunotherapy : CII|November 16, 2020
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)Simon Fietz, Romina Zarbl, Dennis Niebel, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Laryngoscope Investigative Otolaryngology|October 19, 2022
MR-lymphangiography identifies lymphatic pathologies in patients with idiopathic recurrent cervical swellingMarius Vach, Julia Wagenpfeil, Andreas Henkel, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|September 28, 2012
Phase I clinical study of vascular targeting fluorescent cationic liposomes in head and neck cancerSebastian Strieth, Christoph Dunau, Kristina Kolbow, et al.
Pigment Cell & Melanoma Research|November 17, 2023
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanomaLuka de Vos-Hillebrand, Simon Fietz, Philip Hillebrand, et al.
Journal of Materials Chemistry. B|August 10, 2021
Photocleavable core cross-linked polymeric micelles of polypept(o)ides and ruthenium(II) complexesTobias Alexander Bauer, Jonas Eckrich, Nadine Wiesmann, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 7, 2023
Randomized, placebo-controlled study on efficacy, safety and tolerability of drug-induced defibrinogenation for sudden sensorineural hearing loss: the lessons learnedBernhard G Weiss, Jennifer L Spiegel, Sven Becker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2021
DNA Methylation and mRNA Expression of OX40 (TNFRSF4) and GITR (TNFRSF18, AITR) in Head and Neck Squamous Cell Carcinoma Correlates With HPV Status, Mutational Load, an Interferon-γ Signature, Signatures of Immune Infiltrates, and SurvivalSophia M Loick, Anne Fröhlich, Jennis Gabrielpillai, et al.
International Journal of Molecular Sciences|March 11, 2023
Exploiting Vitamin D Receptor and Its Ligands to Target Squamous Cell Carcinomas of the Head and NeckLaura Koll, Désirée Gül, Manal I Elnouaem, et al.
Medical Ultrasonography|September 9, 2020
Evaluation of optimal education level to implement structured reporting into ultrasound trainingBenjamin Philipp Ernst, Sebastian Strieth, Julian Künzel, et al.
Cancer Biology & Therapy|March 18, 2010
Vascular targeting tumor therapy: non-invasive contrast enhanced ultrasound for quantitative assessment of tumor microcirculationMartin E Eichhorn, Laura V Klotz, Siiri Luedemann, et al.
Cancer Immunology, Immunotherapy : CII|November 16, 2020
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)Simon Fietz, Romina Zarbl, Dennis Niebel, et al.
Pageof 12